Last reviewed · How we verify
Carbimazol (CARBIMAZOLE)
At a glance
| Generic name | CARBIMAZOLE |
|---|---|
| Drug class | carbimazole |
| Target | Lactoperoxidase |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Graves' disease
- Hyperthyroidism
Common side effects
Key clinical trials
- Prospective Evaluation of OptiThyDose (NA)
- The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure
- LIthium as Bridging thErapy Prior to Radioactiveiodine in hyperThYroidism (PHASE4)
- Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19
- Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism (PHASE3)
- Antithyroid Drug Treatment of Thyrotoxicosis in Young People (PHASE3)
- Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Carbimazol CI brief — competitive landscape report
- Carbimazol updates RSS · CI watch RSS